Pharmacological targeting of the NLRP3 LRR domain with isothiazolinones overcomes CRID3-resistant inflammation
| Title: | Pharmacological targeting of the NLRP3 LRR domain with isothiazolinones overcomes CRID3-resistant inflammation |
|---|---|
| Authors: | Woo, HawonAff1; Jang, YeonseoAff1; Kim, SoyeonAff1; Kim, WonyoungAff1; Zhang, FenfenAff2; Mall, RaghvendraAff3; Patel, Chirag NAff3, Aff4; Kurera, MelanAff5; Ngo, ChinhAff5; Jiang, Simon HAff5; Nicotra, AsiaAff6; Py, Bénédicte FAff6; Zheng, MinAff2, IDs44321026004255_cor1; Man, Si MingAff5, IDs44321026004255_cor2; Karki, RajendraAff1, Aff7, IDs44321026004255_cor3 |
| Source: | EMBO Molecular Medicine. :1-28 |
| Database: | Springer Nature Journals |